Microtubules assume a variety of structures throughout the different stages of the cell cycle. Ensuring the correct assembly of such structures is essential to guarantee cell division. During mitosis, it is well established that the spindle assembly checkpoint monitors the correct attachment of sister chromatids to the mitotic spindle. However, the role that microtubule cytoskeleton integrity plays for cell-cycle progression during interphase is uncertain. Here we describe the existence of a mechanism, independent of the mitotic checkpoint, that delays entry into mitosis in response to G 2 -phase microtubule damage. Disassembly of the G 2 -phase microtubule array leads to the stabilization of the universal mitotic inhibitor Wee1, thus actively delaying entry into mitosis via inhibitory Cdc2 Tyr15 phosphorylation.
I
N eukaryotic cells, reliable transmission of genetic information requires the replication of DNA during S phase and segregation of the sister chromatids during mitosis. To permit the completion and correct progression of these two critical events, a variety of mechanisms exist by which the cell actively halts cell-cycle progression until earlier processes have been completed. These mechanisms, known as ''checkpoints,'' monitor key processes and can delay cell-cycle progression in the event of a problem (Weinert and Hartwell 1988; May and Hardwick 2006; Callegari and Kelly 2007) . In the fission yeast Schizosaccharomyces pombe, the machinery regulating entry into mitosis has been thoroughly characterized (Nurse 1994) , and a variety of stress and checkpoint signaling pathways that converge upon the proteins that govern the G 2 /M transition have been identified (Suda et al. 2000; Lopez-Aviles et al. 2005; Callegari and Kelly2007) . The key regulator of this transition is the conserved cyclinB/ Cdc2 complex. Activation of this complex, and entry into mitosis, is inhibited by Wee1 kinase, which negatively regulates Cdc2 kinase by phosphorylation of its Tyr15 residue, a phosphorylation step reversed by Cdc25 phosphatase (Nurse 1994) .
In S. pombe, the best-characterized checkpoint operating at the G 2 /M transition is the G 2 -phase DNA damage checkpoint. UV irradiation of fission yeast induces a G 2 -phase delay prior to mitosis onset (al-Khodairy and Carr 1992; al-Khodairy et al. 1994) . Detection of DNA damage or DNA synthesis intermediates results in the activation of a signal transduction cascade mediated by the Rad3 and Chk1 protein kinases that inhibits entry into mitosis (al-Khodairy and Carr 1992; Walworth et al. 1993; Saka et al. 1997) . The link between these checkpoints and the enzymes controlling mitosis is also well established. Chk1 can phosphorylate Cdc25 to create a binding site for 14-3-3 proteins, which in turn inactivates Cdc25 and modifies its subcellular localization (Furnari et al. 1997; Lopez-Girona et al. 1999) . Chk1 also mediates an activating phosphorylation of Wee1, thus providing an additional direct link between the DNA damage checkpoint and core cell-cycle regulation (O'Connell et al. 1997; Lee et al. 2001) .
In addition to those mechanisms involved in verifying the replication and integrity of DNA, cells must possess mechanisms to correctly segregate genetic material into each daughter cell. This task depends on the formation and organization of complex microtubule-based structures. During the fission yeast cell cycle, striking changes take place in the organization of the cytoplasmic microtubule cytoskeleton (Hagan 1998; Sawin and Tran 2006) . At G 2 phase, fission yeast cells typically have three to four bundles of microtubules running along the cell axis. As cells enter mitosis, the cytoplasmic microtubules are disassembled and intranuclear microtubules form the mitotic spindle, which is responsible for separating each set of sister chromatids toward opposite poles that will be divided into the two daughter cells. By the end of mitosis, microtubules are nucleated from the cell division site to form a transient post-anaphase array (Heitz et al. 2001) .
It is well established that the integrity of these microtubule structures is monitored during the M phase. The mitotic checkpoint senses correct spindle assembly, triggering a delay in mitotic progression in the case of unattached kinetochores or a lack of tension between sister chromatids (Asakawa et al. 2006; May and Hardwick 2006) . The mitotic arrest deficiency (Mad) and budding uninhibited by benomyl (Bub) proteins are key components of the mitotic spindle checkpoint conserved in organisms ranging from yeast to humans. The conserved components of the mitotic spindle checkpoint act at various stages of mitosis to coordinate spindle assembly and sister-chromatid separation as well as to delay mitotic exit and cytokinesis in response to spindle defects (Booher and Beach 1988; Mulvihill and Hyams 2002; Musacchio and Salmon 2007) . However, the existence of surveillance mechanisms capable of verifying microtubule integrity prior to the commitment to mitosis is controversial (Uetake and Sluder 2007) . On the basis of the observation that wee1-deficient S. pombe cells were extremely sensitive to microtubuledamaging agents, we initiated the analysis of a link connecting microtubule structures and cell-cycle control, an issue of interest given the number of microtubuletargeting drugs that are currently used as chemotherapeutic agents for cancer patients (Pellegrini and Budman 2005) . Here we report the existence of a novel mechanism in fission yeasts that monitors microtubule integrity during the G 2 phase. This mechanism transiently inhibits entry into mitosis when interphase microtubule structures are compromised.
MATERIALS AND METHODS
Cell culture and strains: Cells were cultured in supplemented minimal medium (EMM) (Moreno et al. 1991) . Synchronous cultures were generated by centrifugal elutriation (Mulvihill et al. 1999) or by a block-and-release strategy using the cdc25-22 mutation (Booher et al. 1989) . When centrifugal elutriation was used, the synchronized culture was monitored during the first cell cycle and early in G 2 during the second cell division round split into two. A total of 75 mg/ml of carbendazim (MBC) dissolved in dimethyl sulfoxide (DMSO) was added to one culture, and the same volume of DMSO, as a negative control, was added to the other. When the block-andrelease strategy was used, the culture was split into two after release; 75 mg/ml MBC dissolved in DMSO was added to onehalf and DMSO alone, as a negative control, was added to the other half. For the spot test, yeast extract medium supplemented as required (YES) was used. Serial dilutions of cells were spotted onto plates with MBC (4 mg/ml) or DMSO as a negative control.
Fluorescence microscopy: DAPI and calcofluor staining were used to stain nuclei and calculate the percentage of septated cells, respectively (Moreno et al. 1991) . Standard anti-b-tubulin immunofluorescence procedures were used to stain microtubule arrays (Woods et al. 1989) . For fixation of histone 3 serine-phosphorylated (PSH3) cells glutaldehyde was omitted from the fixation step and fixation performed with 3% formaldehyde for 5 min . H3SP was detected using the UPSTATE anti-H3SP antibody. Cells were examined using a Leica fluorescence microscope equipped with a Plan Apo 3100 lens.
Western blot: For tyrosine-15-phosphorylated Cdc2 detection, cell extracts were made from exponential growing cultures harvested by centrifugation, washed once in ice-cold Stop buffer (150 mm NaCl, 50 mm NaF, 10 mm EDTA, 1 mm NaN3) and frozen as cell pellets at À80°. Cell pellets were thawed in 200 ml of lysis buffer [150 mm NaCl, 50 mm Tris (pH 8.0), 50 mm NaF, 5 mm EDTA, 1 mm Na3VO4, 1 mm phenylmethylsulfonyl fluoride, 10% glycerol, 1% Nonidet P-40, and 5 mg each of aprotinin, leupeptin, and pepstatin/ml], broken up with a Fast-Prep machine (Bio101) using acid-washed glass beads (Sigma) and centrifuged to prepare a cleared whole-cell extract. For Wee1 detection, the cell pellets were resuspended in 100 ml of RIPA buffer (10 mm sodium phosphate, 1% Triton X-100, 0.1% SDS, 10 mm EDTA, 150 mm NaCl, pH 7.0) containing the following protease inhibitors: 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml pepstatin, 10 mg/ml soybean trypsin inhibitor, 100 mm 1-chloro-3-tosylamido-7-amino-l-2-heptanone, 100 mm N-tosyl-l-phenylalanine chloromethyl ketone, 100 mm phenylmethylsulfonyl fluoride, 1 mm phenanthroline, and 100 mm N-acetyl-leu-leu-norleucinal. Cells were boiled for 5 min and broken using 500 mg of acid-washed glass beads (Sigma) in a Fast-Prep machine (Bio101); the crude extract was recovered by washing with 100 ml of RIPA. All steps were carried out at 4°. For Western analysis, samples were electrophoresed on 12 or 8% polyacrylamide gels and transferred to nitrocellulose membrane. The blots were probed with antibodies against tyrosine-15-phosphorylated Cdc2 (Cell SignalingTechnnology) with mouse monoclonal antibodies against the PSTAIR peptide or anti-HA monoclonal antibody. Goat anti-rabbit or anti-mouse antibody conjugated to horseradish peroxidase (1:1000) was used as a secondary antibody. Immunoblots were developed using the ECL kit (Amersham) and protein levels were quantified using Image J (National Institutes of Health, Bethesda, MD).
RESULTS AND DISCUSSION

Microtubule damage delays entry into mitosis:
Checkpoints are essential for cell-cycle progression. A single defective checkpoint can severely affect the ability of the cell to respond to damage-inducing agents. For example, in budding and fission yeast, mutations in genes required for DNA-damage checkpoints can result in hypersensitivity to UV irradiation (Weinert and Hartwell 1988; al-Khodairy and Carr 1992; al-Khodairy et al. 1994; Callegari and Kelly 2007) . Similarly, deficiencies in the spindle checkpoint can confer hypersensitivity to treatments that disrupt microtubule structures (Asakawa et al. 2006; May and Hardwick 2006) . Interestingly, we observed that wee1-deficient S. pombe cells were extremely sensitive to the presence of the microtubule-depolymerizing drug MBC ( Figure 1A) . In comparison to wild-type cells, wee1D mutants accumulated aberrant nuclei and presented a high percentage of septated cells (cut phenotype) in the presence of MBC (see Figure 1, B and C) . This observation appears to uncover a role for Wee1 in modulating the cell cycle in response to microtubule damage. Wee1 is thought to act primarily at the G 2 /M transition (Nurse 1994) . Therefore, aside from a possible role of this cell-cycle regulator in the mitotic spindle checkpoint (currently under study), we initiated the analysis of a possible mechanism connecting microtubule G 2 structures and cell-cycle control.
To investigate the possibility of a G 2 /M microtubuledamage control in fission yeasts, we prepared S. pombe cells synchronized in early G 2 by centrifugal elutriation. These cells were allowed to progress to early G 2 of the second synchronous cycle (to avoid any effect caused by the elutriation stress), split into two, and treated either with MBC dissolved in DMSO or with DMSO alone as a control. Samples were taken over time and the septation index and histone H3 phosphorylation-an early event of the mitotic prophase )-was monitored ( Figure 1D ). As shown in Figure 1 , E and F (top), interphase microtubules were completely disassembled in wild-type MBC-treated cells, and these cells exhibited a delayed entry into mitosis relative to untreated cells, suggesting the existence of a mechanism that transiently halts the cell cycle during G 2 in response to microtubule damage.
Certain microtubule-damaging agents such as thiabendazole have been shown to also affect actin structures (Sawin and Snaith 2004) . In budding yeast, the morphogenesis checkpoint senses actin or septin structure integrity and can induce a cell-cycle delay via Swe1/ Wee1 (Sia et al. 1998; Keaton and Lew 2006) . Similarly, a size checkpoint control that links actin filaments to a Cdc2 control has been proposed for S. pombe (Rupes et al. 2001) . Thus, although we have used MBC as a highly specific antimicrotubule drug, it is possible that unknown nontubulin targets of MBC could be responsible for the observed G 2 /M delay. To discard this possibility, we used the nda3-TB101 mutant, a strain harboring a point mutation in the nda3 gene (coding for b-tubuline), which confers MBC resistance (Sawin and Snaith 2004) . In this mutant background, the microtubule array is now resistant to the effect of MBC but any other possible MBC target would remain sensitive. As shown in Figure 1 , E and F (bottom), cells possessing the MBC-resistant tubulin completely bypassed the MBC-induced delay. Thus, the G 2 -phase delay following MBC treatment is wholly dependent on its depolymerization of microtubules.
Microtubule-damage signaling operates through Wee1 but not through Cdc25: The canonical G 2 -phase cell-cycle arrest requires inhibitory phosphorylation of Cdc2 catalyzed by Wee1 kinase and opposed by Cdc25 phosphatase (Nurse 1994) . The MBC hypersensitivity of wee1-deficient cells implicates Wee1 as a potential target of the microtubule-damage signaling pathway, but we cannot exclude Cdc25 inhibition from a role in triggering the G 2 delay. To address this possibility, we assessed MBC sensitivity in the cdc2-1w, cdc2-3w, and cdc2-3w cdc25D mutant strains. cdc2-3w is an active allele of cdc2 containing a mutation that relieves the requirement for Cdc25 but retains sensitivity to Wee1. Conversely, cdc2-1w is an active allele containing mutations that result in a Cdc2 variant insensitive to the inhibitory effect of Wee1 but still sensitive to Cdc25 dephosphorylation (Enoch and Nurse 1990 ). If Cdc25 is required for the MBC-induced delay, then the cdc2-3w strain and particularly the cdc2-3w cdc25D strain, should manifest MBC hypersensitivity. As shown in Figure 2A , wee1D and cdc2-1w but not cdc2-3w or cdc2-3w cdc25D mutant cells were hypersensitive to MBC treatment, suggesting that Wee1 but not Cdc25 is involved in this microtubuledamage signaling mechanism.
To determine the role of Wee1 in this delay, we analyzed the effect of MBC during the G 2 /M transition in wee1-deficient cells. Synchronization by centrifugal elutriation of wee1D cells is difficult due to their reduced size. However, by using the thermo-sensitive wee1-50 mutant strain, cells could be synchronized at 25°(permissive temperature) before shifting them to the restrictive temperature for wee1-50, permitting cell-cycle progression and carrying out MBC treatment as described above. The MBC-induced G 2 delay was less prominent in wildtype cells grown at 35°. Thus, the assay was carried out at 30°, where the MBC-induced G 2 delay occurred as at 25°i n wild-type cells (supplemental Figure S1 ) and wee1-50 strains are still defective for Wee1 activity. At this temperature, synchronous wee1-deficient cells bypassed the G 2 delay triggered by MBC ( Figure 2B ), indicating that Wee1 is required to induce the G 2 delay caused by microtubule damage. To confirm that Cdc25 is not required for the G 2 /M delay, we performed similar experiments using synchronized cdc2-3w cdc25D fission yeast cells. We found that S. pombe cells lacking the Cdc25 pathway retained their response to MBC treatment ( Figure  2C ). Taken together, these observations strongly suggest that the G 2 -phase delay induced by microtubule damage is mediated primarily via Wee1 inhibition of Cdc2.
The cdc25-22 thermo-sensitive allele encodes a Cdc25 protein active at 25°and completely inactive at 35° ( Nurse et al. 1976) . At intermediate permissive temperatures (27°-29°), the reduced Cdc25 activity results in a Cdc2-Tyr15 regulation that relies mainly on the Wee1 side of the control and therefore any Wee1 regulatory effect is amplified in this genetic background. Interestingly, growth of this strain was partially sensitive to MBC at 27° (Figure 2D ), but contrary to wee1-deficient cells, MBC treatment in the cdc25-22 strain produced elongated cells with a conventional G 2 -block phenotype ( Figure 2E ). This cell-cycle block was reverted by removing the drug and completely abolished in cdc25-22 wee1D double-mutant cells (data not shown). Thus in a cdc25-22 genetic background, the G 2 -phase delay triggered by MBC became an efficient G 2 arrest, supporting the notion of a microtubule-damage-sensing mechanism that exerts a delay at G 2 /M transition through Wee1. The enhancement of the transient G 2 delay under MBC treatment makes the cdc25-22 mutation a particularly useful tool for studying this novel microtubule-damage signaling response.
A mechanism for the Wee1-mediated inhibition of Cdc2 by G 2 -damaged microtubules: To determine if the Wee1-dependent MBC-induced cell-cycle delay is mediated via the canonical phosphorylation and inhibition of Cdc2, we examined Tyr15 phosphorylation in G 2 synchronized cells by using a cdc25-22 block-and-release strategy (Alfa et al. 1990) . After release at 25°, Tyr15 phosphorylation and septation were determined over time in MBC-or DMSO-(control) treated cells. As shown in Figure 3 , A and B, DMSO-treated cells (control) progressed normally through the cell cycle and the G 2 /M transition was accompanied by a reduction of the level of Tyr15 phosphorylation as expected (Gould and Nurse 1989) . However, tyrosine dephosphorylation of Cdc2 associated with mitotic activation was severely delayed in MBC-treated cells (see Figure 3A) . Thus, the microtubule-damage-dependent G 2 -phase delay acts via Wee1 to promote maintenance of Cdc2 Tyr15 phosphorylation.
Since Wee1 is the direct regulator of Cdc2 Tyr15 phosphorylation in this microtubule-damage response, the Cdc2 inhibitory effect mediated by Wee1 in MBCtreated cells could be exerted by increasing Wee1 activity and/or Wee1 abundance. To gain insight into the mechanism by which microtubule depolymerization inhibits Cdc2, we examined synchronized cells to determine the levels of Wee1 protein during the G 2 /M transition. Using the cdc25-22 block-and-release strategy, the amount of tagged Wee1-HA protein was monitored during the G 2 /M transition in cells treated with either MBC or DMSO (control) ( Figure 3C ). Samples were taken to monitor the progression of the cells through mitosis via PSH3 staining and their septation index ( Figure 3D ). As shown in Figure 3 , C and E, levels of Wee1 protein decreased as cells entered into mitosis in control cells but, significantly, remained high in MBCtreated cells. This result indicates that Wee1 protein levels are involved in triggering a G 2 -phase delay in the response to damage to microtubule structures. On the basis of this observation one might expect that fission yeast cells with higher levels of Wee1 protein would have an enhanced G 2 -phase delay in response to MBC treatment. As shown in Figure 3F , wild-type cells (a single wee1 gene copy per genome) are slightly elongated following MBC treatment, consistent with a transient G 2 delay; however, in cells expressing higher levels of Wee1 (harboring three wee1 gene copies) (Russell and Nurse Figure 2 .-Wee1p mediates the microtubuledamage-induced G 2 -phase delay. (A) MBC (4 mg/ml) growth sensitivity of wild-type S. pombe cells and mutants defective for the Wee1-mediated inhibition of Cdc2 (wee1D and cdc2-1w) or Cdc25-mediated Cdc2 activation (cdc2-3w and cdc2-3w cdc25D). Assays were carried out in YES medium at 25°. (B) Cell-cycle progression with MBC (75 mg/ml) or DMSO of synchronized wee1-50 cells (thermo-sensitive allele). Cells were grown in EMM medium at 25°and after elutriation were shifted to 30°(semirestrictive temperature) and the percentage of phosphorylated histone H3 (left) and the percentage of septated cells (right) was monitored as described in Figure  1E . (C) Cell-cycle progression of synchronized Cdc25-deficient cells (cdc2-3w cdc25D cells) treated with MBC (75 mg/ml) or DMSO as described in Figure 1E . (D) MBC (4 mg/ml) growth hypersensitivity of cdc25-22 S. pombe cells at 27°(semirestrictive temperature). Successive dilutions of wild-type and cdc25-22 cells were spotted onto YES solid medium containing MBC (4 mg/ml) or DMSO. (E) Cell length of each strain and condition was visualized under the microscope. 1987), this delay was significantly enhanced. Thus the G 2 -phase microtubule-damage response appears to be regulated, at least in part, by controlling Wee1 protein levels. Degradation of Wee1 is the main mechanism triggering the decrease in Wee1 levels as cells enter mitosis (McGowan and Russell 1995; Aligue et al. 1997; Muñoz et al. 1999; Watanabe et al. 2005) , suggesting that stabilization of Wee1 is likely involved in the maintenance of this protein during the G 2 /M transition in the presence of microtubule-depolymerizing agents.
The spindle checkpoint represents a well-established signaling mechanism able to detect defects in microtubule structures. Since microtubule disassembly appears to be the cause of the MBC-induced G 2 delay in S. pombe cells, we tested whether this delay was dependent on aspects of the mitotic spindle checkpoint apparatus. We examined the MBC sensitivity of several deletion mu- Figure 3 .-Inhibitory Cdc2-Tyr15 phosphorylation and its regulatory mechanism under microtubule-damaging conditions. (A and C) Cells were synchronized by a block-and-release strategy. The synchronized culture was split into two, MBC (75 mg/ml) or DMSO were added to the cells after release, and aliquots were taken periodically. Extracts were prepared from each aliquot and analyzed by Western blot. (A) Cdc2-Tyr15 phosphorylation (PCdc2) was detected along the G 2 /M transition in the synchronized cdc25-22 strain. Phospho-cdc2 (tyr15) antibody or anti-PSTAIR antibody were used to determine Cdc2-Tyr15 phosphorylation or total Cdc2 protein as a loading control, respectively. tants for components of the mitotic spindle checkpoint, including the spindle checkpoint response genes mad2 and bub1 (mad2D and bub1D, respectively) (Asakawa et al. 2006; May and Hardwick 2006) , as well as in cells deleted for dma1 (dma1D), which is essential in S. pombe for the septation initiation network inactivation in the presence of spindle damage (Murone and Simanis 1996) . Significantly, its mammalian ortholog, Chfr, is implicated in a very early mitotic response to microtubule damage (Matsusaka and Pines 2004) . All of these mitotic checkpoint components were hypersensitive to MBC treatment in a similar fashion to that exhibited by wee1-deficient mutants (see supplemental Figure S2 ). However, according to the Cdc2 Tyr15-phosphorylation assay in synchronous fission yeast cells, the G 2 delay triggered by MBC treatment remained intact in these mutant strains, indicating that the G 2 -phase microtubuledamage response described here is independent of mitotic spindle damage signaling pathways (supplemental Figure S3 ).
In budding yeasts, a G 2 -phase arrest has been reported in response to microtubule perturbation during meiosis (Hochwagen et al. 2005) , but equivalent mechanisms operating during the mitotic cycle has not been described so far. In mammalian cells, the ''antephase checkpoint'' seems to regulate early steps of the mitotic phase during the mitotic cycle in response to microtubule disassembly (Matsusaka and Pines 2004) . However, whether this checkpoint is independent of the spindle checkpoint remains unclear. It has been recently described that the integrity of the microtubule cytoskeleton is not subjected to checkpoint surveillance in normal human cells (Uetake and Sluder 2007) . In this study, the authors describe an interphase duration of 4 hr longer than that of the control (24 hr vs. 20 hr on average) in nocodazole-treated populations of primary fibroblasts. This delay, which is consistent with the MBCinduced delay described in this study for S. pombe cells, is attributed to a stress caused by the loss of microtubules. In S. pombe, stress delays entry into mitosis by activation of the p38/Sty1 MAP kinase pathway (Suda et al. 2000; Lopez-Aviles et al. 2005) . As occurred with mutants for the spindle checkpoint, the MBC-mediated delay in G 2 was also observed in sty1D cells defective for these MAPkinase-signaling stress conditions (supplemental Figure  S4) , thereby excluding this pathway of the mechanism delaying the G 2 /M transition by microtubule injuries. Thus, we conclude that the results described in our study uncover a mechanism (a G 2 -phase microtubule-damage checkpoint) that links interphase microtubule integrity with entry into mitosis in fission yeasts.
Checkpoint defects are often associated with cancer cells (Kastan and Bartek 2004) . The identification of new damage-sensing mechanisms in different cell structures, capable of arresting the cell cycle, could lead to new approaches to cancer treatment ( Janetka et al. 2007 ). In the mechanism described in this study, stabilization of the universal Wee1 kinase is essential for the cell response to microtubule perturbation. Several microtubuletargeting drugs are used as chemotherapeutic drugs for human cancer patients (Pellegrini and Budman 2005) . On the basis of our observations, selective Wee1 inhibition or degradation could be used to sensitize tumor cells to antimicrotubule agents for therapeutic applications. The ability to manipulate such a novel checkpoint may even provide the basis for completely novel anticancer treatments.
